GlassScriptPhysician profile
Laura Ledvora
NPI 1427554682
$525.61
in general payments reported to CMS, 2019-2025
17 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $56.34 · 2024: $235 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $162.13 | 2024 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.17 | 2025 | Caplyta |
| Abbvie INC. | $35.47 | 2025 | |
| Dexcom, INC. | $33.12 | 2023-2024 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $24.10 | 2025 | Auvelity |
| Lundbeck LLC | $22.73 | 2025 | Rexulti |
| Exact Sciences Corporation | $22.50 | 2023 | Cologuard Collection Kit |
| Neos Therapeutics, LP | $21.48 | 2025 | Adzenys Xr-Odt |
| Amphastar Pharmaceuticals, INC. | $20.06 | 2024 | |
| Owp Pharmaceuticals, INC. | $19.49 | 2025 | Subvenite |
| Heartflow, INC. | $18.83 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $18.25 | 2025 | Cobenfy |
| Corium, LLC | $18.02 | 2025 | Azstarys |
| Glaxosmithkline, LLC. | $17.78 | 2023 | Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $17.09 | 2025 | Trintellix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $17.07 | 2024 | Gvoke Hypopen |
| Idorsia Pharmaceuticals US INC | $16.32 | 2025 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Ledvora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.